CCNE1 and Alzheimer disease: Our lab previously demonstrated that brains from transgenic mouse models of AD show altered expression of P-cdc-2, cyclin D1, and cyclin E, together with enhanced phosphorylation of APP at Thr668 (Judge et al. 2011).